OPEN END TURBO OPTIONSSCHEIN SHORT - STRYKER CORP. Share Price

Certificat

DE000GP48D89

Market Closed - BOERSE MUENCHEN 19:26:00 10/05/2024 BST
18.31 EUR +0.44% Intraday chart for OPEN END TURBO OPTIONSSCHEIN SHORT - STRYKER CORP.
Current month+2.35%
1 month+9.44%
Date Price Change Volume
10/05/24 18.31 +0.44% 0
09/05/24 18.23 -1.35% 0
08/05/24 18.48 +0.60% 0
07/05/24 18.37 -2.29% 0
06/05/24 18.8 +1.51% 0

Real-time BOERSE MUENCHEN

Last update May 10, 2024 at 07:26 pm

More quotes

Static data

Product typeKnock-Out without Stop Loss
Buy / SellPUT
Underlying STRYKER CORPORATION
Issuer Goldman Sachs
WKN GP48D8
ISINDE000GP48D89
Date issued 23/05/2023
Strike 527.7 $
Maturity Unlimited
Parity 10 : 1
Emission price 22.17
Emission volume N/A
Settlement cash
Currency EUR

Technical Indicators

Highest since issue 25.95
Lowest since issue 15.4

Company Profile

Stryker Corporation is one of the world's leaders in designing, manufacturing, and selling orthopedic equipments. Net sales break down by family of products as follows: - surgical equipments and neurotechnology products (57.5%): electric motorized surgical instruments, surgical navigation systems, endoscopy equipment, digital imaging systems, neurosurgery equipments, neurovascular devices, etc. The group also offers hospital beds, gurneys, stretchers, and emergency room equipment; - orthopedic implants (42.5%): joint prostheses, traumatology implants, micro-implants, orthopedic cement, orthobiology products, etc. The group also provides spinal implants. At the end of 2022, the group had 48 production sites worldwide. Net sales are distributed geographically as follows: the United States (73.9%), Europe/Middle East/Africa (12.7%), Asia/Pacific (10.2%) and other (3.2%).
Sector
-
More about the company

Ratings for Stryker Corporation

Trading Rating
Investor Rating
ESG Refinitiv
A-
More Ratings

Consensus: Stryker Corporation

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
29
Last Close Price
330.6 USD
Average target price
372.4 USD
Spread / Average Target
+12.64%
Consensus